& Securities

May 6, 2021 — Weil partners Jon-Paul Bernard (Mergers & Acquisitions), Adé Heyliger (Public Company Advisory) and Mark Hoenig (Tax) and counsel Ami Zweig (Employment Litigation) presented on a panel titled “Risks and Opportunities Through the Legal Lens” as part of The Harvard Business School Associations of Boston, New York and Northern California’s 2021 Nonprofit Board Summit: Building High Impact Nonprofit Boards During Dynamic Times.

January 29, 2021 — Public Company Advisory Group partner P.J. Himelfarb spoke on key MD&A issues for the 2020 annual report on Form 10-K and 2021 quarterly reports on Form 10-Q as part of PLI’s Sixth Annual Dealing with MD&A Hot Topics.

January 26, 2021 — Public Company Advisory Group partner P.J. Himelfarb spoke on a panel titled “Recurring Disclosure Challenges” as part of Northwestern Law’s 48th Annual Securities Regulation Virtual Institute. The panel discussed COVID-19: what more to say in 2021?; new human capital disclosures; dealing with contingencies and legal proceedings; guidance: updating it, withdrawing it, restarting it; and complications from share buybacks and Rule 10b5-1 plans.

January 12, 2021 — Public Company Advisory Group partner Lyuba Goltser spoke on a panel titled “Streamlined MD&A and Financial Disclosures: Early Considerations” as part of The Corporate Counsel’s Webcast Series.

January 12, 2021 — Public Company Advisory Group partner Adé Heyliger spoke on a panel titled “Cultivating the Next Generation of Diverse Board Members” as part of the Council of Urban Professionals and Goldman Sachs Pipeline to Power Summit. The presentation covered the future of board composition, trends across public, private, corporate and not-for-profit boards and how diverse professionals can be a part of this next generation of board members.

November 4, 2020 — Public Company Advisory Group partner Adé Heyliger spoke on a panel titled “Disclosure Developments for Public Companies” as part of PLI’s 52nd Annual Institute on Securities Regulation. The presentation covered known trends and uncertainties – drafting an effective MD&A with the uncertainties of COVID-19; performance metrics (KPIs); earnings releases – best practices and tips for drafting; Corp Fin’s Disclosure Review Program – observations and priorities; status of SEC disclosure rulemaking initiatives; and getting risk factors right and capturing COVID-19 risks effectively.